Tirzepatide Dual Agonist | GIP • GLP-1 Tirzepatide is a dual incretin receptor agonist engineered to activate both GIP and GLP-1 receptors, providing coordinated metabolic signaling across multiple physiological pathways. Designed for advanced research applications, it supports investigation into glucose regulation, insulin signaling, energy homeostasis, and weight-related metabolic mechanisms. ________________________________________ Specifications • Form: Lyophilized powder Freeze-dried powder form for stable storage and easy reconstitution. • Quantity: 20 mg per vial • 99% Purity – HPLC Tested ________________________________________ Handling & Storage Store in a cool, dry place away from light. Refrigeration required after reconstitution store between 5-8 degrees ________________________________________ Quality Standard Lab Tested and Manufactured under controlled conditions and supplied as research-grade material. ________________________________________ Shipping Express shipping available within Australia.
